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Calcium has been shown to r egulate the proliferation 
of epidermal keratinocy tes in vitro_ We became inter-
ested in the role of the calcium binding protein, calmo-
dulin, in h y perproliferative, low calcium regulated ke-
ratinocytes in vitr o and in the in vivo h yperproliferative 
state, psorias is. Calmodulin levels were measured b y 
radioimmune assay in neonatal mouse keratinocy tes 
grown in 0.02 mM calcium (hyperproliferative) and 1.2 
mM calcium (normal) media, and in cells that had been 
grown in low calcium medium and then switched to 
normal calcium- On a whole culture basis the normal 
cells had more calmodulin than the low calcium cells. 
However, when low calcium monolayers were compared 
to the normal basal monolayer, the low calcium hyper-
proliferative cells had more calmodulin. Cells that were 
switched from 0.02 mM calcium to 1.2 mM calcium 
showed increasing calmodulin levels over time. P so-
riatic plaques contained 2- 3 times more calmodulin than 
the skin of norma l controls w hen examined on a per /J.g 
of DNA, per /J.g of protein, and per gram of wet weight 
basis. Adjacent uninvolved psoriatic skin also had sig-
nificantly eleva ted calmodulin levels in all data bases 
e xcept per /J.g of protein/cm2 • These data suggest that 
increased calmodulin levels are associated with epider-
mal hyperproliferation and/or with the state of differ-
entiation. 
Calcium and its binding protein calmodulin have been shown 
to m odul ate growth a nd prolife ration in a number of cell types. 
H ennings et a ! have shown t hat calcium m ay p lay a role in t h e 
control of prolife ration of ke ratinocytes in vit ro (1] . When t he 
ionic calc ium con ce nt ration of t he growt h medium was reduced 
to 0.02- 0.09 mM , the cells became hyperprolife rative a nd fa iled 
to form desmosomes or t o stratify. Restoration of t he calc ium 
to n orma l (1.2 mM ) levels caused t he cells to s low t heir pro lif-
e rative rate a nd to termina lly di ffe ren t iate. 
Calmodulin is a 16,700 molecula r weight acidic p rotein which 
binds to a nd modula tes the actions of calc ium. It has been 
ident ified in skin [2- 4]. Calmodulin is involved in t he regula-
t ion of enzymes such as calcium-dependent protein kinase [5], 
phospholipase A2 (6], a nd phosphodiesterase (7], as well as 
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regulat io n of cell proliferation (8]. We becam e interested in t he 
role of calmodulin in epiderma l hyperprolife rative states both 
in vi t ro a nd in vivo. W e report here t he measurem en t of 
calmodulin levels in t h e hyperproliferative, low calcium system 
in vi t ro, a nd t he in vivo hyperproliferative state, psoriasis. 
MATERIALS AND METHODS 
Reagents 
Neonatal mice were obtained from the BALB/ c colony at t he De-
partment of Dermatology, the University of Michigan. Media 199 (M -
199) with and without calcium were purchased from Gibco Laboratories 
(Grand Island, New York ). Fetal bovine serum (FBS), penicill in and 
streptomycin , and Dulbecco's phosphate-buffe red saline (PBS) were 
obtained from Flow Laboratories, Inc. (Rockville, Maryland). Fico)) 
400 and trypsin (2x crysta llized) were purchased from Sigma Chemical 
Company (St. Louis, Missouri ). Chelex 100 was purchased from Bio-
Rad, Inc. (Richmond, California). Calmodulin was obtained from Cal-
biochem-Behring (La J olla, California). Calmodul in radioimmune as-
say kits were obtained from New England Nuclear (Boston, Massachu -
setts). Corning plastic products were used throughout for cell cul ture 
preparation and growth. All other chemicals were reagent grade. 
Epidermal Keratinocyte Cultures 
Isolation of basal cells from neonatal BALB/ c mice was perfo rmed 
as described by Marcelo et al [9). T he cells were plated in M-199 with 
1.2 mM (normal) or 0.02 mM (low) calcium plus 10% FBS (v/ v) 
conta ining 50 IU/ml of penicillin and 50 1-'g/ ml of streptomycin. Low 
calcium medium was prepared using M-199 wi thout calcium, and 
Chelex-treated FBS, 10% [10) . The calcium concentration of t he me-
dium plus FBS was t hen measured by calcium ion electrode wi t h 
microprocessor ionanalyzer. Treatment wit h Chelex reduced the cal-
cium concentration to 0.001 mM or less. Calcium chloride was added 
to the medium to adjust t he concentration to 0.02 mM and the concen-
tration was rechecked by bioassay using morphologic changes and 
repeat ion electrode measurement. All cultures were grown in 5% C02 
in air , humidified gassing at 32"C in 35-mm Petri dishes. The medium 
was changed every other day. 
Keratome Biopsy Specimens 
Skin samples were obta ined from t he involved and uninvolved skin 
of untreated psoriatics (n = 9) and from the skin of normal volunteers 
(n = 10). Approximately 2.0 x 4.0 em strips were removed with a Storz 
keratome after 1% Xylocaine anesthesia. Depth was 0.2 mm in normal 
and uninvolved specimens and 0.4 mm in psoriatic plaque to minimize 
dermal contamination. The area of the removed skin was recorded and 
the specimens were snap-frozen in liquid nit rogen . T he wet weight of 
the specimens was recorded and the samples were ground to a fine 
powder wit h mortar and pestle while still frozen. 
Extraction and Measurements of Calmodulin 
Calmodulin was ext racted from epidermal cell cultures and skin 
biopsy specimens by a modification of t he method of Iizuka et a! [3). 
The cells were grown in low or normal calcium medium fo r 7 days. At 
t hat t ime half of the low calcium cells were switched to normal calcium 
medium. The swi tched cells were then harvested at 24, 48, 96, and 168 
h (7 days) afte r switching along with low and normal calcium controls. 
The cells were washed in PBS and scraped from the dish into a fi nal 
volume of 500 1-'1 per dish of 20 mM Tris-HCI, pH 7.5, wit h 1 mM 
EGTA. Cells from 4- 5 dishes were pooled and briefly sonicated. Ali -
quots were removed fo r DNA and total protein measurement. T he 
extract was brought to 95"C in a boiling-water bath for 5 min and 
cooled in a methanol-liquid ni t rogen bath. The cells were t hen spun at 
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10,000 g fo r 30 min. The resulting calmodul in-containing superna tant 
was removed and the calmodulin content measured. Calmodulin con-
tent was measured us ing the commerically avai lable RIA kit with non-
heat-treated controls. Stude nt's t-test fo r paired and unpa ired data was 
used fo r statistical analysis. Nonparametric a nalysis gave t he same 
significance. 
DNA and Protein Assay 
The aliquot removed for DNA and protein was precipitated with 6% 
T CA and t he DNA in t he pellet resuspended and hydrolyzed with 3% 
perchloric acid at 95"C for 15 min. After centrifugation, t he supernatant 
was assayed for DNA by t he method of Burton [11] . The protein pellet 
was dissolved in 1 N NaOH and assayed in triplicate for protein content 
usin g a Lowry protein assay (1 2]. 
Removal of S tratified Cell Layers 
Seven-day-old cells grown in normal calcium were incubated with 
0.24 M ammonium chloride at 4"C for 15 min. Beta mercaptoethanol 
(0. 1 M) was t hen added, and t he ce lls incubated for an additional 15 
min. T he incubation solu t ion was t hen removed, the cells washed with 
PBS, and t he upper, strat ified layers were removed with a gentle stream 
of PBS [13]. This leaves a confluent monolayer on the bottom of the 
Pet ri dish which is comparable to the low calcium monolayer (Fig 1). 
Calmodulin content of the upper, stratified cell layers and the basal 
monolayer was measured. 
RESULTS 
Calmodulin Levels in Psoriatic and Normal Shin 
Calmodulin levels were grossly elevated in involved psoriatic 
epidermis when compared to normal skin or uninvolved pso-
FIG 1. a, Low calcium monolayer. b, 1.2 mM calcium basal mono-
layer after removal of upper, stratifted ce ll s with ammonium chloride. 
a and b, X 125. 
Vol. 84, No.3 
UvsN IvsU IvsN 
103%-f- 117%t 341%1' 
.025<p< .05 .005<p< .OI p<.OOI 
• 
• 
•• 
col ~ 
z 
:J • 
:::> 
0 10 • 0 
3 •• •• 
ct • • 0 5 •• co • • • c • • 
• 
u I 
FIG 2. Calmodulin content in epidermis of 10 normal (N) and 9 
psoriatic involved (1) and uninvolved ( U) subjects expressed per 11g 
DNA. Mean ± SEM. 
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FIG 3. Calmodulin content in epidermis of 10 normal (N) and 9 
psoriatic involved (/) and uninvolved ( U) subjects expressed per 11g of 
protein per cm2• Mean ± SEM. 
ria t ic skin. Comparisons were made using several different data 
bases: !Lg DNA (Fig 2), J.Lg protein/cm2 (Fig 3) , and grams wet 
weight (Fig 4). Psoriatic uninvolved skin showed elevated cal-
modulin levels when compared to normal skin. This increase 
was not as great as in the involved skin but was statistically 
significant in all data bases except !Lg protein/em" (p = .1) 
(Fig3). 
Calmodulin Levels in Cell Culture 
Calmodulin levels in tissue culture were compared on 3 data 
bases: per J.Lg DNA, per J.Lg protein, and per Petri dish (Fig 5) . 
The hyperproliferat ive, low calcium cells appeared to have less 
calmodulin when analyzed on a per dish (p < 0.001) or per J.Lg 
of DNA (p = 0.001) basis. However, when examined on a per 
!Lg of protein basis, the hyperproliferative cells had slightly 
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more calmodulin, though t his increase was not significant (p = 
0.1). 
Low calcium cells that were switched to normal (1.2 mm) 
calcium at day 7 gradually increased their calmodulin content 
over the next 7 days (Fig 5). Forty-eight hour data are not 
shown, as they gave no additiona l information. In order to 
determine whether these differences were due to the monolayer, 
nonstratified nature of the low calcium cells, the upper, differ-
entiated ce ll layers were removed with ammonium chloride as 
described in Materials and Methods. 
The resu lts of the ca lmodulin assays on the stratified layers 
vs the basal monolayer, vs the low calcium monolayer are shown 
in Table I. When the low calcium monolayer is compared to 
the equivalent no rmal calcium monolayer on a per Petri basis, 
the hyperproliferative cell s contain more calmodulin (p = 
0.005). When examined on a per pg of DNA basis, the low 
calcium hyperproliferative cells again have a significant in-
crease in the amount of calmodulin they contain (p = 0.05). 
The final data base per J.Lg of protein, showed a slight increase 
in calmodulin content, though this was not significant (p < 
0.5). 
DISCUSSION 
The psoriatic data presented confirm and expand the work 
of van de Kerkhof and van Erp [14) who demonstrated an 
increase in the calmodu lin content in psoriatic p laque on a per 
J.L g of DNA basis. Recently the biologic activity of calmodulin 
has also been shown to be elevated in psoriasis [15) . Our data 
demonstrated this increase in epidermal p laque calmodulin 
using several data bases that have been suggested as correct for 
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FIG 4. Calmodu lin content in epidermis of 10 normal (N) and 9 
psoriatic involved (!) and uninvolved ( U) subjects expressed per gram 
of wet weight. Mean ± SEM. 
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psoriasis. In addition, uninvolved psoriatic skin adjacent to 
plaque had higher levels of calmodulin compared to normal 
skin. This elevation was statistically significant in all data 
bases studied except per J.Lg of protein/cm2• 
In vitro, calmodulin was elevated in the 1.2 mM calcium 
multi layered cultures when compared to the low calcium cells. 
T his elevation was significant in all data bases except per J.Lg 
of protein . When cells grown to 7 days of age in low calcium 
medium were then switched to normal calcium medium, the 
calmodulin levels increased gradually over the next 7 days (Fig 
5). These results suggested that the low calcium cell cultures 
contain less calmodulin than their normal calcium counter-
parts. However, this difference appears to be due to the mon-
olayer nature of the low calcium cells, rather than representing 
their true content. 
If normal basal monolayers that have had the differentiated 
upper layers removed are compared to low calcium regulated 
basal cell monolayers, the hyperproliferative, low calcium cells 
contain more calmodulin than the normal monolayers. This 
increase was significant in all data bases except per J.Lg of 
protein. 
These results suggest t hat calmodulin levels may fluctuate 
over the functional lifespan of epidermal keratinocytes. The 
low calcium regulated keratinocyte appears to have more cal-
modulin than normal basal cells. This suggests that increases 
in calmodulin are related to the proliferative state of the 
keratinocyte: cells with an increased rate of proliferation have 
increased amounts of calmodulin. 
Chalfou leas et al have demonstrated that increases in cal-
modulin occur in the cell cycle during late G1 and/or early S 
phase [16]. Since psoriatic cells have been shown to have an 
increase in the number of cycling cells [17), this may account 
for the elevations of calmodulin compared to normal cells. In 
cell culture, 90% of the low calcium cells are in the growth 
fraction compared to 60% of normal calcium cells (lj. The same 
mechanism for the elevation of calmodulin levels may be op-
erative as in psoriasis. 
An alternative hypothesis may be that calmodulin levels are 
related to t he differentiation state of the cells. The low calcium 
regu lated keratinocytes are both hyperproliferative [1) and 
TABLE I. Amounts of calmodulin present in 1.2 mM Ca ++ stratified 
layers, basal m.onolayers, and 0.02 mM monolayers on day 7 after 
plating (mean ± SEM, n. = 4) 
Stratified layer 
(1.2 mM Ca++) 
Basal monolayer 
(1.2 mM Ca++) 
Low calcium monolayer 
(0.02 mM Ca++) 
For p values, see text. 
0 LOW CO'' (0.02 mM) 
NORMAL Co••(l.2mM} 
SWITCHED AT BASELI NE 
FROM LOW to 1.2 mM Co" 
ng Calmodulin 
per Petri ng Calmodulin 
dish per l'g DNA 
ng 
Calmodulin 
per l'g protein 
212.5 ± 30 14.3 ± 1.5 0.42 ± 0.17 
32.5 ± 9 9.1 ± 1.5 0.27 ± 0.04 
84.9 ± 11 13.1 ± 6.0 0.32 ± 0.07 
FIG 5. Calmodulin content in nor-
mal, low, and "switched" calcium cells. 
Expressed in 3 different data bases. 
Mean ± SEM, n = 4. 
BASELINE 24h 96h 7d BASELINE 24h 96 h 7d BASELI NE 24h 96h 7d 
nQ CALMODULIN I PETRI nQ CAUAOOULIN I f'O DNA CALMOOULINif<O PROTE IN 
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have more differentiated protein compared to a normal basal 
cell. The low calcium cells contain increased amounts of kera-
tohyaline gra nule protein when compared to normal cells [18) 
and also con tain s light amounts of keratin [18,19) . Involucrin, 
an early m arker of terminal differentiation , can a lso be found 
in low calcium regulated keratinocytes [20). When calcium 
levels a re restored to the normal range, the presence of invo-
lucrin becomes localized to the upper cell layers [20] . This 
suggests t hat the low calcium regulated keratinocyte is an 
intermediate cell type which is capable of producing some of 
t he proteins associated with terminal differentiation, but is 
unable to further process t hese proteins for full differentiation 
and stratification . Therefore, it is possible that the increased 
amount of calmodulin in the low calcium regulated keratinocyte 
is not a part of the hyperproliferative state of the cells but is, 
instead, re lated to the partially differentiated state of the low 
calcium regulated keratinocyte. The in vivo state of psoriasis 
may be a na logous to t he in vitro low calcium regulated system , 
i.e., t he existence of hyperproliferative epidermal cells [21,22) 
undergoing incomplete differentiation [23-26). 
The increases in calmodulin seen in low calcium regulated 
keratinocytes a nd pso riasis are associated with increased num-
bers of differentiation characteristics and/or with the hyper-
proliferation state . The psoriatic basal cell population may also 
contain an intermediate cell type: one capable of hyperprolifer-
ation and production of a number of differentiation proteins 
but unable to differentiate fully. 
Calcium and its binding proteins have potential for regula -
tion of a number of keratinocyte functions. The development 
of t he low calcium hyperproliferative system has given us a 
system in which to test for calcium regulation . Our work 
suggests that some of t he information gained from these cells 
may be applicable to in vivo states such as psoriasis. Further 
work will need to focus on the interactions of the calcium 
system with cyclic AMP, Ca-dependent protein kinase, and 
.phospholipase in the epidermis. 
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